{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:48:05Z","timestamp":1780404485013,"version":"3.54.1"},"reference-count":52,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_pp-2025-0020_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Peritoneal mesothelioma (PM) shares features with genitourinary (GU) malignancies, including histologic appearance, embryologic origin and genetic predispositions. However, data on their co-occurrence are limited. The study presents a case series of PM patients with associated GU malignancies and explores outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2025-0020_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospectively maintained CRS-HIPEC database from a tertiary referral center (2011\u20132024) was reviewed. Demographics, tumor characteristics and outcomes were compared between PM patients with and without GU malignancies (including gynecologic and urologic cancers).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2025-0020_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 237\u00a0CRS-HIPEC patients, 8\/17 patients with PM were found to have another GU malignancy (median age\u00a052.8, 62.5\u202f% male). This included renal cell carcinoma, prostate cancer, ovarian tumors and cervical carcinoma. Most GU malignancies were diagnosed before PM (5\/8), two were diagnosed post-CRS-HIPEC, and one synchronously. Three patients reported asbestos exposure; two had\n                      <jats:italic>BAP1<\/jats:italic>\n                      mutations. Compared to those without GU malignancies, affected patients tended to have higher PCI (19.8 vs. 14.3) and poorer 3-year survival (62.5 vs. 100\u202f%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2025-0020_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>GU malignancy is common among PM patients undergoing CRS-HIPEC and could represent a higher-risk subgroup. These findings raise the hypothesis of a potential association between PM and GU malignancy. Shared origins, oncogenesis of similar cell types, environmental exposures or genetic predispositions may contribute and warrant further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/pp-2025-0020","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:57:26Z","timestamp":1761944246000},"page":"177-184","source":"Crossref","is-referenced-by-count":1,"title":["Co-occurrence of peritoneal mesothelioma and genitourinary cancers: a case series with comparative outcomes"],"prefix":"10.1515","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3250-6465","authenticated-orcid":false,"given":"Emma M.","family":"Bradley","sequence":"first","affiliation":[{"name":"Division of Surgical Oncology and Endocrine Surgery, Section of Surgical Sciences , 12328 Vanderbilt University Medical Center , Nashville , TN , USA"},{"name":"Veterans Affairs Hospital, Tennessee Valley Healthcare System, Nashville Campus, Vanderbilt University Medical Center , Nashville , TN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Rogers","sequence":"additional","affiliation":[{"name":"Vanderbilt University School of Medicine, Vanderbilt University Medical Center , Nashville , TN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa C.","family":"Kuo","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology and Endocrine Surgery, Section of Surgical Sciences , 12328 Vanderbilt University Medical Center , Nashville , TN , USA"},{"name":"Veterans Affairs Hospital, Tennessee Valley Healthcare System, Nashville Campus, Vanderbilt University Medical Center , Nashville , TN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Magge","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology and Endocrine Surgery, Section of Surgical Sciences , 12328 Vanderbilt University Medical Center , Nashville , TN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"2025121816430082878_j_pp-2025-0020_ref_001","doi-asserted-by":"crossref","unstructured":"Hiriart, E, Deepe, R, Wessels, A. Mesothelium and malignant mesothelioma. J\u00a0Dev Biol 2019;7:7. https:\/\/doi.org\/10.3390\/jdb7020007.","DOI":"10.3390\/jdb7020007"},{"key":"2025121816430082878_j_pp-2025-0020_ref_002","doi-asserted-by":"crossref","unstructured":"Marinaccio, A, Binazzi, A, Di Marzio, D, Scarselli, A, Verardo, M, Mirabelli, D, et al.. Incidence of extrapleural malignant mesothelioma and asbestos exposure, from the Italian national register. Occup Environ Med 2010;67:760\u20135. https:\/\/doi.org\/10.1136\/oem.2009.051466.","DOI":"10.1136\/oem.2009.051466"},{"key":"2025121816430082878_j_pp-2025-0020_ref_003","doi-asserted-by":"crossref","unstructured":"Drevinskaite, M, Patasius, A, Kevlicius, L, Mickys, U, Smailyte, G. Malignant mesothelioma of the tunica vaginalis testis: a rare case and review of literature. BMC Cancer 2020;20:162. https:\/\/doi.org\/10.1186\/s12885-020-6648-3.","DOI":"10.1186\/s12885-020-6648-3"},{"key":"2025121816430082878_j_pp-2025-0020_ref_004","doi-asserted-by":"crossref","unstructured":"Mezei, G, Chang, ET, Mowat, FS, Moolgavkar, SH. Epidemiology of mesothelioma of the pericardium and tunica vaginalis testis. Ann Epidemiol 2017;27:348\u201359.e11. https:\/\/doi.org\/10.1016\/j.annepidem.2017.04.001.","DOI":"10.1016\/j.annepidem.2017.04.001"},{"key":"2025121816430082878_j_pp-2025-0020_ref_005","doi-asserted-by":"crossref","unstructured":"Goldblum, J, Hart, WR. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors. Am J Surg Pathol 1995;19:1124\u201337. https:\/\/doi.org\/10.1097\/00000478-199510000-00003.","DOI":"10.1097\/00000478-199510000-00003"},{"key":"2025121816430082878_j_pp-2025-0020_ref_006","doi-asserted-by":"crossref","unstructured":"Miyamoto, T, Hayashi, H, Sengoku, K, Ojima, H, Tokusashi, Y, Yaginuma, Y, et al.. Diffuse malignant mesothelioma of the uterus. Acta Obstet Gynecol Scand 2000;79:154\u20135. https:\/\/doi.org\/10.1034\/j.1600-0412.2000.079002154.x.","DOI":"10.1034\/j.1600-0412.2000.079002154.x"},{"key":"2025121816430082878_j_pp-2025-0020_ref_007","unstructured":"Ta\u015fk\u0131n, S, G\u00fcm\u00fc\u015f, Y, Kiremit\u00e7i, S, Kahraman, K, Sert\u00e7elik, A, Orta\u00e7, F. Malignant peritoneal mesothelioma presented as peritoneal adenocarcinoma or primary ovarian cancer: case series and review of the clinical and immunohistochemical features. Int J Clin Exp Pathol 2012;5:472\u20138."},{"key":"2025121816430082878_j_pp-2025-0020_ref_008","doi-asserted-by":"crossref","unstructured":"Clement, PB, Young, RH, Scully, RE. Malignant mesotheliomas presenting as ovarian masses: a report of nine cases, including two primary ovarian mesotheliomas. Am J Surg Pathol 1996;20:1067. https:\/\/doi.org\/10.1097\/00000478-199609000-00004.","DOI":"10.1097\/00000478-199609000-00004"},{"key":"2025121816430082878_j_pp-2025-0020_ref_009","doi-asserted-by":"crossref","unstructured":"Moolgavkar, SH, Meza, R, Turim, J. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005. Cancer Causes Control 2009;20:935\u201344. https:\/\/doi.org\/10.1007\/s10552-009-9328-9.","DOI":"10.1007\/s10552-009-9328-9"},{"key":"2025121816430082878_j_pp-2025-0020_ref_010","doi-asserted-by":"crossref","unstructured":"Helm, JH, Miura, JT, Glenn, JA, Marcus, RK, Larrieux, G, Jayakrishnan, TT, et al.. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol 2015;22:1686\u201393. https:\/\/doi.org\/10.1245\/s10434-014-3978-x.","DOI":"10.1245\/s10434-014-3978-x"},{"key":"2025121816430082878_j_pp-2025-0020_ref_011","doi-asserted-by":"crossref","unstructured":"Boffetta, P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 2007;18:985\u201390. https:\/\/doi.org\/10.1093\/annonc\/mdl345.","DOI":"10.1093\/annonc\/mdl345"},{"key":"2025121816430082878_j_pp-2025-0020_ref_012","doi-asserted-by":"crossref","unstructured":"Keefe, DL, Winkler, N. Chapter 1\u00a0\u2013\u00a0embryology. In: Sokol, AI, Sokol, ER, editors. General gynecology [Internet]. Philadelphia: Mosby; 2007, [cited 2025 Apr 15]:1\u201320 pp. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780323032476100012.","DOI":"10.1016\/B978-032303247-6.10001-2"},{"key":"2025121816430082878_j_pp-2025-0020_ref_013","doi-asserted-by":"crossref","unstructured":"Attanoos, RL, Webb, R, Dojcinov, SD, Gibbs, AR. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology 2002;40:237\u201344. https:\/\/doi.org\/10.1046\/j.1365-2559.2002.01352.x.","DOI":"10.1046\/j.1365-2559.2002.01352.x"},{"key":"2025121816430082878_j_pp-2025-0020_ref_014","doi-asserted-by":"crossref","unstructured":"Serao, A, Ambrosini, F, Cavallone, B, Borra, T, Di Stasio, A. Spontaneous urinary bladder perforation: an unusual presentation of well-differentiated papillary peritoneum mesothelioma. Urologia 2022;89:641\u20134. https:\/\/doi.org\/10.1177\/03915603211001181.","DOI":"10.1177\/03915603211001181"},{"key":"2025121816430082878_j_pp-2025-0020_ref_015","unstructured":"Dousias, V, Chouliara, S, Zioga, C, Koliopoulos, G, Lolis, ED, Dalkalitsis, N, et al.. Replacement of the uterus by malignant mesothelioma of the periteneum: a case report. [Internet]; 2001. [cited 2025 Apr 15]. Available from: https:\/\/www.ejgo.net\/articles\/10.12892\/ejgo200103233."},{"key":"2025121816430082878_j_pp-2025-0020_ref_016","doi-asserted-by":"crossref","unstructured":"Ong Mingjing, N, Asamu, AS, Pace, K, Bugeja, S. Peritoneal mesothelioma with invasion of the urinary bladder 20\u00a0years post radiation therapy for colon adenocarcinoma. J\u00a0Surg Case Rep 2021;2021:rjab392. https:\/\/doi.org\/10.1093\/jscr\/rjab392.","DOI":"10.1093\/jscr\/rjab392"},{"key":"2025121816430082878_j_pp-2025-0020_ref_017","doi-asserted-by":"crossref","unstructured":"Huang, Y, Alzahrani, NA, Liauw, W, Morris, DL. Effects of sex hormones on survival of peritoneal mesothelioma. World J Surg Oncol 2015;13:210. https:\/\/doi.org\/10.1186\/s12957-015-0624-4.","DOI":"10.1186\/s12957-015-0624-4"},{"key":"2025121816430082878_j_pp-2025-0020_ref_018","doi-asserted-by":"crossref","unstructured":"Pina, M, Fernandes, R, Fonseca, D, Oliveira, C, Rodrigues, A. A case report of mesothelioma response to endocrine therapy in synchronous breast cancer and pleural epithelioid mesothelioma: a double exemestane effect. Cureus 2022;14:e31579. https:\/\/doi.org\/10.7759\/cureus.31579.","DOI":"10.7759\/cureus.31579"},{"key":"2025121816430082878_j_pp-2025-0020_ref_019","doi-asserted-by":"crossref","unstructured":"Carbone, M, Yang, H, Pass, HI, Krausz, T, Testa, JR, Gaudino, G. BAP1 and cancer. Nat Rev Cancer 2013;13:153\u20139. https:\/\/doi.org\/10.1038\/nrc3459.","DOI":"10.1038\/nrc3459"},{"key":"2025121816430082878_j_pp-2025-0020_ref_020","doi-asserted-by":"crossref","unstructured":"Attanoos, RL, Thomas, DH, Gibbs, AR. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals. Histopathology 2003;43:387\u201392. https:\/\/doi.org\/10.1046\/j.1365-2559.2003.01685.x.","DOI":"10.1046\/j.1365-2559.2003.01685.x"},{"key":"2025121816430082878_j_pp-2025-0020_ref_021","doi-asserted-by":"crossref","unstructured":"Chen, T, Kharazmi, E, Lou, J, Zhang, X, Sundquist, K, Hemminki, K. Risk of second primary cancers after malignant mesothelioma and vice versa. Cancer Lett 2016;14:e31579. https:\/\/doi.org\/10.1016\/j.canlet.2016.05.034.","DOI":"10.1016\/j.canlet.2016.05.034"},{"key":"2025121816430082878_j_pp-2025-0020_ref_022","doi-asserted-by":"crossref","unstructured":"Pandav, V, Patel, J, Inampudi, JV, Li, S, Mahadevia, H, Koshiya, H, et al.. Incidence of additional primary malignancies in patients with malignant peritoneal mesothelioma. J\u00a0Clin Orthod 2023;41:e20535. https:\/\/doi.org\/10.1200\/jco.2023.41.16-suppl.e20535.","DOI":"10.1200\/JCO.2023.41.16_suppl.e20535"},{"key":"2025121816430082878_j_pp-2025-0020_ref_023","doi-asserted-by":"crossref","unstructured":"Malpica, A, Euscher, ED, Marques-Piubelli, ML, Ferrufino-Schmidt, MC, Miranda, RN, Sams, R, et al.. Malignant mesothelioma of the peritoneum in women: a clinicopathologic study of 164 cases. Am J Surg Pathol 2021;45:45\u201358. https:\/\/doi.org\/10.1097\/pas.0000000000001545.","DOI":"10.1097\/PAS.0000000000001545"},{"key":"2025121816430082878_j_pp-2025-0020_ref_024","doi-asserted-by":"crossref","unstructured":"Lu, Y, Milchgrub, S, Khatri, G, Gopal, P. Metachronous uterine endometrioid adenocarcinoma and peritoneal mesothelioma in Lynch syndrome: a case report. Int J Surg Pathol 2017;25:253\u20137. https:\/\/doi.org\/10.1177\/1066896916680745.","DOI":"10.1177\/1066896916680745"},{"key":"2025121816430082878_j_pp-2025-0020_ref_025","unstructured":"Lewis, CR, Uchic-Boccella, J, Zimmerman, J, Miller, E, Liang, S, Wagner, PL. Synchronous well-differentiated papillary mesothelioma and endometrioid adenocarcinoma arising from endometriosis. EBSCOhost [Internet] 2024;38, [cited 2025 Apr 30]:191. https:\/\/doi.org\/10.46883-2F2024.25921020. Available from: \u200bhttps:\/\/openurl.ebsco.com\/contentitem\/d\u200boi:10.46883%2F2024.25921020?sid=ebsco:plink:crawler&id=ebsco:d\u200boi:10.46883%2F2024.25921020."},{"key":"2025121816430082878_j_pp-2025-0020_ref_026","doi-asserted-by":"crossref","unstructured":"Chen, YY, Li, PC, Hsu, YH, Ding, DC. Peritoneal well-differentiated papillary mesothelioma coexisting with endometrial adenocarcinoma mimicking peritoneal carcinomatosis: a case report. Taiwan J Obstet Gynecol 2020;59:968\u201371. https:\/\/doi.org\/10.1016\/j.tjog.2020.09.031.","DOI":"10.1016\/j.tjog.2020.09.031"},{"key":"2025121816430082878_j_pp-2025-0020_ref_027","doi-asserted-by":"crossref","unstructured":"McGinnis, JM, Bloomfield, V, Kazerouni, H, Helpman, L. Well-differentiated papillary mesothelioma with two synchronous serous gynaecologic carcinomas in a 62-Year-old woman: lessons learned for the gynaecologic surgeon. J\u00a0Obstet Gynaecol Can 2020;42:1262\u20136. https:\/\/doi.org\/10.1016\/j.jogc.2019.12.012.","DOI":"10.1016\/j.jogc.2019.12.012"},{"key":"2025121816430082878_j_pp-2025-0020_ref_028","doi-asserted-by":"crossref","unstructured":"Losi, L, Botticelli, L, Taccagni, G, Longinotti, E, Lancellotti, C, Scurani, L, et al.. Malignant peritoneal mesothelioma in a woman with bilateral ovarian serous borderline tumour: potential interactions between the two diseases. Gynecologic Oncology Reports 2018;24:39\u201342. https:\/\/doi.org\/10.1016\/j.gore.2018.03.003.","DOI":"10.1016\/j.gore.2018.03.003"},{"key":"2025121816430082878_j_pp-2025-0020_ref_029","doi-asserted-by":"crossref","unstructured":"Yano, M, Ikeda, Y, Kato, T, Sakaki, M, Sato, S, Yabuno, A, et al.. A case of peritoneal malignant mesothelioma following radiation therapy for cervical cancer. Mol Clin Oncol 2018;8:302\u20135. https:\/\/doi.org\/10.3892\/mco.2017.1525.","DOI":"10.3892\/mco.2017.1525"},{"key":"2025121816430082878_j_pp-2025-0020_ref_030","doi-asserted-by":"crossref","unstructured":"Farioli, A, Violante, FS, Mattioli, S, Curti, S, Kriebel, D. Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database. Cancer Causes Control 2013;24:1535\u201345. https:\/\/doi.org\/10.1007\/s10552-013-0230-0.","DOI":"10.1007\/s10552-013-0230-0"},{"key":"2025121816430082878_j_pp-2025-0020_ref_031","doi-asserted-by":"crossref","unstructured":"Manzini, Vde P, Recchia, L, Cafferata, M, Porta, C, Siena, S, Giannetta, L, et al.. Malignant peritoneal mesothelioma: a multicenter study on 81 cases. Ann Oncol 2010;21:348\u201353. https:\/\/doi.org\/10.1093\/annonc\/mdp307.","DOI":"10.1093\/annonc\/mdp307"},{"key":"2025121816430082878_j_pp-2025-0020_ref_032","unstructured":"Candura, SM, Boeri, R, Teragni, C, Chen, Y, Scafa, F. Renal cell carcinoma and malignant peritoneal mesothelioma after occupational asbestos exposure: case report. Med Lav 2016;107:172\u20137."},{"key":"2025121816430082878_j_pp-2025-0020_ref_033","unstructured":"Kawakita, M, Kamoto, T, Okabe, T, Matsumoto, M. [Renal cell carcinoma with malignant peritoneal mesothelioma: report of a case]. Hinyokika Kiyo 1992;38:937\u201340."},{"key":"2025121816430082878_j_pp-2025-0020_ref_034","unstructured":"Murinello, A, Carvalho, A, Figueiredo, AM, Dam\u00e1sio, H, Murillo, MJ, Nunes, G, et al.. Primary malignant peritoneal mesothelioma associated with renal cell carcinoma \u2013 a concise review based on a clinical case. Journal J Port Gastroenterol 2010;17:217\u201322."},{"key":"2025121816430082878_j_pp-2025-0020_ref_035","doi-asserted-by":"crossref","unstructured":"Basatac, C, Aktepe, F, Sa\u011flam, S, Akp\u0131nar, H. Synchronous presentation of muscle-invasive urothelial carcinoma of bladder and peritoneal malign mesothelioma. Int Braz J Urol 2019;45:843\u20136. https:\/\/doi.org\/10.1590\/s1677-5538.ibju.2018.0815.","DOI":"10.1590\/s1677-5538.ibju.2018.0815"},{"key":"2025121816430082878_j_pp-2025-0020_ref_036","doi-asserted-by":"crossref","unstructured":"Brahim, D, Mechergui, N, Ben Said, H, Cherif, D, Ladhari, N, Youssef, I. Peritoneal mesothelioma associated with bladder cancer and occupational exposure to asbestos: a case report. Clin Case Rep 2020;8:3529\u201332. https:\/\/doi.org\/10.1002\/ccr3.3465.","DOI":"10.1002\/ccr3.3465"},{"key":"2025121816430082878_j_pp-2025-0020_ref_037","doi-asserted-by":"crossref","unstructured":"Tassile, D, Roth, AD, Kurt, AM, Rohner, A, Morel, P. Colon cancers and peritoneal mesothelioma occurring 29\u00a0years after abdominal radiation for testicular seminoma: a case report and review of the literature. Oncology 1998;55:289\u201392. https:\/\/doi.org\/10.1159\/000011865.","DOI":"10.1159\/000011865"},{"key":"2025121816430082878_j_pp-2025-0020_ref_038","doi-asserted-by":"crossref","unstructured":"Obrist, R, Wegmann, W, Kiss, D. [Prostate cancer with an unusual course]. Onkologie 1990;13:388\u201391. https:\/\/doi.org\/10.1159\/000216801.","DOI":"10.1159\/000216801"},{"key":"2025121816430082878_j_pp-2025-0020_ref_039","doi-asserted-by":"crossref","unstructured":"Courelli, AS, Sharma, AK, Madlensky, L, Choi, YY, Li, S, Sarno, S, et al.. Co-localization of gastrointestinal stromal tumors (GIST) and peritoneal mesothelioma: a case series. Ann Surg Oncol 2022;29:7542\u20138. https:\/\/doi.org\/10.1245\/s10434-022-12211-x.","DOI":"10.1245\/s10434-022-12211-x"},{"key":"2025121816430082878_j_pp-2025-0020_ref_040","doi-asserted-by":"crossref","unstructured":"Siegel, RL, Kratzer, TB, Giaquinto, AN, Sung, H, Jemal, A. Cancer statistics. CA Cancer J Clin 2025;75:10\u201345, https:\/\/doi.org\/10.3322\/caac.21871.","DOI":"10.3322\/caac.21871"},{"key":"2025121816430082878_j_pp-2025-0020_ref_041","doi-asserted-by":"crossref","unstructured":"Calthorpe, L, Romero-Hernandez, F, Miller, P, Conroy, PC, Hirose, K, Kim, A, et al.. Contemporary trends in malignant peritoneal mesothelioma: incidence and survival in the United\u00a0States. Cancers (Basel) 2022;15:229. https:\/\/doi.org\/10.3390\/cancers15010229. PMID: 36612225; PMCID: PMC9818958.","DOI":"10.3390\/cancers15010229"},{"key":"2025121816430082878_j_pp-2025-0020_ref_042","doi-asserted-by":"crossref","unstructured":"Ullah, A, Waheed, A, Khan, J, Mishra, A, Tareen, B, Nama, N, et al.. Incidence, survival analysis and future perspective of primary peritoneal mesothelioma (PPM): a population-based study from SEER database. Cancers (Basel) 2022;14:942. https:\/\/doi.org\/10.3390\/cancers14040942. PMID: 35205689; PMCID: PMC8869829.","DOI":"10.3390\/cancers14040942"},{"key":"2025121816430082878_j_pp-2025-0020_ref_043","doi-asserted-by":"crossref","unstructured":"Carbone, M, Kratzke, RA, Testa, JR. The pathogenesis of mesothelioma. Semin Oncol 2002;29:2\u201317. https:\/\/doi.org\/10.1053\/sonc.2002.30227.","DOI":"10.1053\/sonc.2002.30227"},{"key":"2025121816430082878_j_pp-2025-0020_ref_044","doi-asserted-by":"crossref","unstructured":"Spirtas, R, Heineman, EF, Bernstein, L, Beebe, GW, Keehn, RJ, Stark, A, et al.. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med 1994;51:804\u201311. https:\/\/doi.org\/10.1136\/oem.51.12.804.","DOI":"10.1136\/oem.51.12.804"},{"key":"2025121816430082878_j_pp-2025-0020_ref_045","doi-asserted-by":"crossref","unstructured":"Franco, N, Godono, A, Clari, M, Ciocan, C, Zunarelli, C, Pira, E, et al.. Occupational asbestos exposure and urinary bladder cancer: a systematic review and meta-analysis. World J Urol 2023;41:1005\u201315. https:\/\/doi.org\/10.1007\/s00345-023-04327-w.","DOI":"10.1007\/s00345-023-04327-w"},{"key":"2025121816430082878_j_pp-2025-0020_ref_046","doi-asserted-by":"crossref","unstructured":"Malpica, A, Euscher, ED, Marques-Piubelli, ML, Miranda, RN, Fournier, KF, Raghav, KP, et al.. Malignant peritoneal mesothelioma associated with endometriosis: a clinicopathologic study of 15 cases. Int J Gynecol Pathol 2022;41:59\u201367. https:\/\/doi.org\/10.1097\/pgp.0000000000000762.","DOI":"10.1097\/PGP.0000000000000762"},{"key":"2025121816430082878_j_pp-2025-0020_ref_047","doi-asserted-by":"crossref","unstructured":"Butnor, KJ, Rueckert, J, Pavlisko, EN, Sporn, TA, Roggli, VL. Malignant peritoneal mesothelioma in patients with endometriosis. J\u00a0Clin Pathol 2018;71:971\u20134. https:\/\/doi.org\/10.1136\/jclinpath-2018-205099.","DOI":"10.1136\/jclinpath-2018-205099"},{"key":"2025121816430082878_j_pp-2025-0020_ref_048","unstructured":"Abdul Rahim, SN, Ho, GY, Coward, JIG. The role of interleukin-6 in malignant mesothelioma. Transl Lung Cancer Res 2015;4:55\u201366. https:\/\/doi.org\/10.3978\/j.issn.2218-6751.2014.07.01."},{"key":"2025121816430082878_j_pp-2025-0020_ref_049","doi-asserted-by":"crossref","unstructured":"Yan, TD, Popa, E, Brun, EA, Cerruto, CA, Sugarbaker, PH. Sex difference in diffuse malignant peritoneal mesothelioma. Br J Surg 2006;93:1536\u201342. https:\/\/doi.org\/10.1002\/bjs.5377.","DOI":"10.1002\/bjs.5377"},{"key":"2025121816430082878_j_pp-2025-0020_ref_050","doi-asserted-by":"crossref","unstructured":"Pillai, K, Pourgholami, MH, Chua, TC, Morris, DL. Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma. J\u00a0Cancer Res Clin Oncol 2013;139:987\u201394. https:\/\/doi.org\/10.1007\/s00432-013-1408-2.","DOI":"10.1007\/s00432-013-1408-2"},{"key":"2025121816430082878_j_pp-2025-0020_ref_051","doi-asserted-by":"crossref","unstructured":"Hiltbrunner, S, Fleischmann, Z, Sokol, ES, Zoche, M, Felley-Bosco, E, Curioni-Fontecedro, A. Genomic landscape of pleural and peritoneal mesothelioma tumours. Br J Cancer 2022;127:1997\u20132005. https:\/\/doi.org\/10.1038\/s41416-022-01979-0.","DOI":"10.1038\/s41416-022-01979-0"},{"key":"2025121816430082878_j_pp-2025-0020_ref_052","doi-asserted-by":"crossref","unstructured":"Sugarbaker, PH. Update on the management of malignant peritoneal mesothelioma. Transl Lung Cancer Res 2018;7:599\u2013608. https:\/\/doi.org\/10.21037\/tlcr.2018.08.03.","DOI":"10.21037\/tlcr.2018.08.03"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0020\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0020\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:52:18Z","timestamp":1766076738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0020\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,9,26]]},"published-print":{"date-parts":[[2025,12,16]]}},"alternative-id":["10.1515\/pp-2025-0020"],"URL":"https:\/\/doi.org\/10.1515\/pp-2025-0020","relation":{},"ISSN":["2364-768X"],"issn-type":[{"value":"2364-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]}}}